T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics

World Journal of Gastroenterology

Volumn 12, Issue 18, 2006, Pages 3015-3019

  Tang, Jie Tang ^a   Fang, Jing Yuan ^a,b   Gu, Wei Qi ^a   Li, En Lin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Digestive Disease   (China)

Author keywords

Fibrogenesis; Hepatic inflammatory activity; Interferon activity; T cell immune responses

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN TYPE 4; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; HYALURONIC ACID; INTERLEUKIN 10; INTERLEUKIN 2; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROLOGY;

EID: 33744547629     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i19.3015     Document Type: Article

References (21)

1. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, Macias MA, Rendon P, Diaz F, Fernandez-Gutierrez C, Martin-Herrera L. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004; 24: 437-445
2. Tsukamoto T, Yamamoto T, Ikebe T, Takemura S, Shuto T, Kubo S, Hirohashi K, Kinoshita H. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Hepatogastroenterology 2004; 51: 777-780
3. Desmet VJ, Gerber M, Hoofnagle JH, Marms M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520
4. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20: 349-355
5. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003; 27: 109-116
6. Lee M, Lee M, Lee SK, Son M, Cho SW, Park S, Kim HI. Expression of Thl and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients. J Korean Med Sci 1999; 14: 175-181
7. Anastassakos C, Alexander GJ, Wolstencroft RA, Avery JA, Portmann BC, Panayi GS, Dumonde DC, Eddleston AL, Williams R. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988; 94: 999-1005
8. Priimiagi LS, Tefanova VT, Tallo TG, Shmidt EV, Solomonova OV, Tuisk TP, Kikosh GV, Krupskaia LM, Lisitsyna SA. TH1-cytokines in chronic hepatitis B and C. Vopr Virusol 2002; 47: 23-27
9. Xie Y, Zhao H, Dai WS, Xu DZ. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 2003; 2: 418-422
10. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 1998; 28: 471-479
11. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology 1992; 16: 776-784
12. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-1199
13. Tao J, Cai WM, Lu LW, Chen QW, Weng HL, Zhang YS. Expression of BcL-2 and Bax proteins in rat liver fibrosis model and the role of IFN-ganuna. Zhonghua Ganzangbing Zazhi 2003; 11: 669-672
14. Simsek H, Kadayifci A. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy. J Int Med Res 1996; 24: 239-245
15. Sawayama Y, Hayashi J, Kawakami Y, Furusyo N, Ariyama I, Kishihara Y, Ueno K, Kashiwagi S. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection. Dig Dis Sci 1999; 44: 163-169
16. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U. Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology 2002; 36: 1001-1008
17. Hyodo N, Nakamura L Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol 2004; 135: 462-466
18. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003; 27: 109-116
19. Kato M, Ikeda N, Matsushita E, Kaneko S, Kobayashi K. Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by Concanavalin A. Hepatol Res 2001; 20: 232-243
20. Louis H, Le Moine 0, Goldman M, Deviere J. Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 2003; 66: 7-14
21. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000; 118: 655-660